Stock Events

Arrowhead Pharmaceuticals (ARWR) Q4 2023 Earnings

29NovConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.92
-1.13
-0.34
0.45

Details

Expected EPS
-0.61
Actual EPS
-1.92
Surprise EPS
-1.31
Surprise Percent
+214.75%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -1.92 per share for Q4 2023.

0 Comments

Share your thoughts